Kassim Javaid
Associate Professor
- University Lecturer in Metabolic Bone Disease
Kassim Javaid studied medicine at Charing Cross and Westminster Medical School, and did his house jobs in London. He then finished a three year SHO rotation in medicine at Southampton General Hospital followed by 8 months as a registrar before starting at the MRC Environmental Epidemiology Unit in October 2000.
His research areas are in epidemiology and adult metabolic bone disease focusing vitamin D, osteoporosis, secondary fracture prevention and rare bone diseases.
Key publications
-
Determinants of the Maternal 25-Hydroxyvitamin D Response to Vitamin D Supplementation During Pregnancy.
Journal article
Moon RJ. et al, (2016), J clin endocrinol metab, 101, 5012 - 5020
Recent publications
-
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment.
Journal article
Kamenicky P. et al, (2023), Rmd open, 9
-
Expected benefits and budget impact from a microsimulation model support the prioritisation and implementation of Fracture Liaison Services.
Journal article
Pinedo-Villanueva R. et al, (2023), J bone miner res
-
Assessing a 12-month course of oral alendronate for adults with avascular necrosis of the hip: MANTIS RCT with internal pilot.
Journal article
Glyn-Jones S. et al, (2022), Health technol assess, 26, 1 - 58
-
Anti‐osteoporosis medication dispensing by clinical commissioning groups in England – an ecological study of variability in practice and of the effect of the Covid‐19 pandemic
Journal article
Janjua SS. et al, (2022), Pharmacoepidemiology and drug safety
-
Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study.
Journal article
Brandi ML. et al, (2022), Calcif tissue int